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Commitment to the T and natural killer T (NKT)
cell lineages is determined during ab T cell
receptor (TCR)-mediated interactions of com-
mon precursors with ligand-expressing cells in
the thymus. Whereas mainstream thymocyte
precursors recognize major histocompatibility
complex (MHC) ligands expressed by stromal
cells, NKT cell precursors interact with CD1d
ligands expressed by cortical thymocytes. Here,
we demonstrated that such homotypic T-T in-
teractions generated ‘‘second signals’’ medi-
ated by the cooperative engagement of the ho-
mophilic receptors Slamf1 (SLAM) and Slamf6
(Ly108) and the downstream recruitment of
the adaptor SLAM-associated protein (SAP)
and the Src kinase Fyn, which are essential
for the lineage expansion and differentiation of
the NKT cell lineage. These receptor interac-
tions were required during TCR engagement
and therefore only occurred when selecting
ligands were presented by thymocytes rather
than epithelial cells, which do not express
Slamf6 or Slamf1. Thus, the topography of
NKT cell ligand recognition determines the
availability of a cosignaling pathway that is
essential for NKT cell lineage development.
INTRODUCTION
Natural killer T (NKT) cells constitute a separate lineage of
innate-like T lymphocytes involved in various infectious,
autoimmune, allergic, and cancerous conditions (Bende-
lac et al., 2006; Godfrey et al., 2004). They emerge from
the thymus asmemory or effector cells that explosively re-
lease T helper 1 (Th1) and Th2 cytokines and chemokines
upon recognition, through conserved semi-invariant ab TImcell receptors (TCRs), of glycolipid ligands presented by
themajor histocompatibility complex (MHC)-like molecule
CD1d. There is growing evidence indicating that differen-
tial signaling associated with TCR recognition of ligands at
the CD4+CD8+ double-positive (DP) stage of thymic
development underlies the divergence betweenNKT cells,
mainstream CD4 and CD8 T cells, regulatory T cells, and
CD8aa cells (Benlagha et al., 2005; Gapin et al., 2001;
Jordan et al., 2001; Leishman et al., 2002; Yamagata
et al., 2004). However, the specific nature of these differ-
ences and their molecular basis have remained elusive.
NKT cells exhibit autoreactivity to CD1d-expressing
cortical thymocytes (Bendelac, 1995), and the dominant
subset expressing Va14-Ja18 and Vb8, 7, or 2 TCRs
(Park et al., 2001) recognizes endogenous ligands such
as iGb3 as weak agonists (Schumann et al., 2006; Zhou
et al., 2004). In contrast, conventional T cells recognize
thymic peptides presented by MHC proteins as partial
agonists (Hogquist et al., 1994). Importantly, the develop-
ment of NKT cells is unique because it relies on ligand
expression by cortical thymocytes (Coles and Raulet,
2000; Schumann et al., 2005; Wei et al., 2005). Indeed,
CD1d expression by cortical thymocytes alone was both
required and sufficient in vivo for positive selection,
lineage expansion, and differentiation into the NKT cell
lineage. This could impact their lineage differentiation
because some of the signals emanating from such homo-
typic thymocyte-thymocyte interactions during TCR rec-
ognition of ligands probably differ from those associated
with heterotypic thymocyte-stromal cell interactions.
Interestingly, the ectopic expression of MHC class II by
the thymocytes of mice expressing the class II transacti-
vator (CIITA) transgene driven by a CD4 promoter resulted
in the selection of CD4+ T cells expressing a memory or
effector phenotype similar to that of NKT cells (Choi
et al., 2005; Li et al., 2005). Furthermore, mice lacking
Tec kinases developed memory or effector CD8+ T cells
that also resembled NKT cells in their expression of NK
lineage markers and in their dependence on MHC class I
ligand expression by bone marrow rather than epi-
thelial cells (Atherly et al., 2006; Broussard et al., 2006).munity 27, 751–762, November 2007 ª2007 Elsevier Inc. 751
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signals provided by bone-marrow-derived selecting cell
types might contribute to the differentiation of memory
or effector lineages (Locksley, 2002).
Indirect evidence suggests that members of the signal-
ing lymphocytic-activation molecule (SLAM) family of
receptors might be involved in this process. These pro-
teins, which are all encoded in the SLAM locus, are mostly
homotypic self-associating receptors expressed by cells
of hemopoietic origin (Engel et al., 2003; Veillette, 2006).
They have recently emerged as TCR-dependent or -inde-
pendent regulators of adhesion and cellular activation
during interactions between mature T, B, macrophage,
and dendritic cells, and they control several aspects of
innate and adaptive responses, as well as chronic dis-
eases (Cannons et al., 2006; Crotty et al., 2003; Howie
et al., 2005; Kumar et al., 2006;Wang et al., 2004). Despite
intricate patterns of expression of several of the SLAM
family receptors during hematopoiesis (Kiel et al., 2005)
and thymopoiesis, their role in lymphocyte development
has not been demonstrated. In T cells and thymocytes,
SLAM-receptor-initiated signaling is mediated in part by
SLAM-associated protein (SAP, also called SH2D1A), an
adaptor that recruits Src kinase Fyn, which in turn phos-
phorylates SLAM receptors. The receptors then serve as
a docking site for a set of signaling molecules (Engel
et al., 2003; Veillette, 2006). Mice lacking Fyn or SAP
exhibited severe NKT cell defects, as did humans with
the X-linked lymphoproliferative (XLP) syndrome associ-
ated with SAP mutation (Chung et al., 2005; Eberl et al.,
1999; Gadue et al., 1999; Nichols et al., 2005; Pasquier
et al., 2005). On the basis of these observations, it could
be envisioned that a costimulatory pathway involving
SAP and Fyn is recruited by SLAM family receptors at
some critical stage of NKT cell development (Borowski
and Bendelac, 2005). However, in mice lacking the
SLAM family receptors Slamf6 (Ly108, NTBA), Slamf1
(SLAM, CD150), or Slamf3 (Ly9, CD229), NKT cell devel-
opment seemed unperturbed (Graham et al., 2006; Howie
et al., 2005; Wang et al., 2004). Other reports have sug-
gested that Fyn could be activated downstream of TCR
signaling (Hermiston et al., 2002) and that SAP could func-
tion without binding Fyn (Cannons et al., 2006; Chan et al.,
2003; Gu et al., 2006; Howie et al., 2002; Simarro et al.,
2004), raising the possibility that Fyn and SAP mediate in
part separate pathways contributing to NKT cell develop-
ment that might be independent of SLAM-family recep-
tors. Thus, the precise pathways recruiting SAP and Fyn
during NKT cell development remain enigmatic. In addi-
tion, the developmental stages at which they are required
have not been characterized. Contrasting with the hypoth-
esis that SAP and Fyn costimulate TCR signaling, the ap-
parent restoration of NKT cell development in Fyn/mice
by the transgenic expression of the canonical Va14-Ja18
TCRa chain has suggested that Fyn acted at early stages
of development upstream of TCR expression and there-
fore prior to thymic positive selection (Gadue et al., 2004).
Here we used genetic and bone-marrow chimera
approaches to provide evidence for a linear pathway of752 Immunity 27, 751–762, November 2007 ª2007 Elsevier Incsignaling that is initiated by homophilic self association
of Slamf1 and Slamf6 expressed by cortical thymocytes
and is propagated by SAP and Fyn. Importantly, we
showed that this pathway was recruited during the TCR
signaling events driving the positive selection of NKT cell
precursors. Furthermore, we demonstrated that, although
unessential for positive selection, Slamf1 and Slamf6
signaling critically controlled the characteristic expansion
and differentiation of the NKT cell lineage that follows
thymic selection.
RESULTS
NKT Cell Developmental Arrest in the Absence
of SAP and Fyn
We first examined whether the NKT cell defects in Fyn or
SAP mutants preceded or followed Va14-Ja18 TCR ex-
pression (Gadue et al., 2004). We found similar frequen-
cies of canonical Va14-Ja18 rearrangements in sorted
DP thymocytes from wild-type, SAP- or Fyn-deficient
mice (Figure 1A), ruling out a role of SAP or Fyn in the gen-
eration of the canonical NKT TCR a chain.We then directly
analyzed the NKT cell developmental defects in different
Fyn- and SAP-deficient mice. In Va14-Ja18 transgenic
mice, Fyn ablation reduced by 85% the frequency of
mature NKT thymocytes identified by CD1d-aGalCer
tetramers and low expression of the heat-stable antigen
CD24 (Figure 1B). Furthermore, the ablation of SAP, which
in SLAM-receptor signaling functions upstream of Fyn,
induced a nearly complete block in the development of
mature NKT cells. The less severe phenotype of Fyn mu-
tants might suggest compensation by other Src kinases,
such as Lck (Simarro et al., 2004). To extend these obser-
vations to nontransgenic thymocytes and further charac-
terize the arrested stage, we stained rare developmental
intermediates with allophycocyanin (APC)-conjugated
CD1d-aGalCer tetramers and enriched them with anti-
APC paramagnetic beads. This enrichment procedure
allows the unambiguous detection by the fluorescence-
activated cell sorting (FACS) of the few hundred CD24hi
Tetramerhi CD69hi NKT cell lineage precursors that are
present in the normal thymus and represent the stage
that immediately follows positive selection (Benlagha
et al., 2005). As shown in Figure 1C, NKT cell development
was arrested at the CD24hi Tetramerhi CD69hi stage in
both SAP- and Fyn-deficient thymocytes. The develop-
mental block in Fyn-deficient mice again appeared to be
leaky because rare cells (<1% of wild-type) reached the
mature CD24lo stage. The arrested cells were reduced in
numbers compared with wild-type cells, and they ex-
pressed CD69, a marker of positive selection, albeit at
a 66% reduced frequency. A similar arrest at the CD24hi
Tetramerhi CD69hi stage after positive selection by CD1d
ligand was observed in Va14-Ja18 transgenic thymocytes
lacking SAP (Figure 1D). Together, these results demon-
strate that the NKT cell developmental arrest in SAP- or
Fyn-deficient mice occurs not only after TCR expression
but also during or just after positive selection..
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Slamf Receptors Control NKT Cell DevelopmentFigure 1. NKT Cell Developmental Arrest in SAP- and Fyn-Deficient Mice
(A) Conserved frequency of Va14-Ja18 rearrangements in Fyn- and SAP-deficient thymocytes. Quantitative reverse transcriptase (RT)-PCR of canon-
ical Va14-Ja18 rearrangements and Ca in sorted DP thymocytes from WT, Fyn/, Ja18/, and CD1d/ (left) and in DP thymocytes from CD1d/
Sh2d1a+/+ and CD1d/Sh2d1a/ mice (right). Sh2d1a/ mice were crossed onto a CD1d/ background so that any contamination of DP
thymocyte by mature NKT cells could be eliminated. The values shown are ratios between Va14-Ja18 and Ca transcripts (mean + standard deviation
[SD], n = 3).
(B) Va14-Ja18 transgenic thymocytes on a Fyn+/+, Fyn/, or SAP/ background were stained with CD1d-aGalCer tetramers and CD24 so that the
immature CD24hi and mature CD24lo stages could be enumerated. Cell frequencies are indicated in the corresponding gates.
(C) CD1d-aGalCer tetramer-positive thymocytes were enriched by autoMACS from pools of thymi obtained from 2-week-old Sh2d1a+/ and
Sh2d1a/ littermates and Fyn/ and Ja18/ mice prior to FACS analysis with CD24 (left column). Numbers in the CD1d-aGalCer+ CD24hi and
CD24lo gates represent absolute cell numbers recovered from two pooled thymi. Gated CD1d-aGalCer+ CD24hi cells were analyzed for CD69 expres-
sion (right column). Percentages are indicated over corresponding brackets. Similar results were obtained in three independent experiments.
(D) Stage of NKT cell developmental arrest in the Va14 Tg Sh2d1a/ thymus. CD1d-aGalCer tetramer+ thymocyteswere enrichedwith paramagnetic
beads and submitted to FACS analysis as in (C). One of two experiments with similar results is shown.Thymic Expression Pattern of SLAM
Family Receptors
We next addressed the question of whether and which
SLAM family members might be involved in NKT cell de-
velopment. The SLAM locus comprises genes encoding
several SAP-binding family members that are conserved
in mouse and human, including Slamf1 (SLAM, CD150),
Slamf3 (Ly9, CD229), Slamf4 (2B4, CD244), Slamf5
(CD84), and Slamf6 (Ly108, NTBA) (Engel et al., 2003; Veil-
lette, 2006). By using monoclonal antibodies, we found
that Slamf4 was not expressed on mouse thymocytesIm(data not shown). Of the remaining receptors, Slamf1
and Slamf6 displayed the highest expression on DP corti-
cal thymocytes with conserved or decreased expression
on mature single-positive (SP) thymocytes, a pattern
similar to CD1d (Roark et al., 1998), whereas Slamf3
and Slamf5 had lower expression on DP than SP cells
(Figure 2A). Developing NKT thymocytes had a similar
pattern of expression, with Slamf1 being rapidly downre-
gulated after the DP stage, whereas Slamf6 expression
persisted longer, until the CD24lo stage (Figure 2B). Fur-
thermore, Slamf1 and Slamf6 were conspicuously absentmunity 27, 751–762, November 2007 ª2007 Elsevier Inc. 753
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Slamf Receptors Control NKT Cell DevelopmentFigure 2. Expression Pattern of SLAM Family Members on Thymocytes and NKT Cells
(A) Double negative (DN), double positive (DP) andmature single positive (SP) thymocytes fromB6mice (or BALB/c for Slamf3 [Ly9]) were analyzed for
the expression of SLAM family receptors. DP cells are represented by a solid black line, SP cells by a dashed dark gray line, andDN cells by a light gray
line, as indicated. Shaded profiles represent isotype controls or staining of thymocytes lacking the corresponding gene or epitope.
(B) Slamf1 and Slamf6 expression at different stages of NKT thymocyte development. Left panels show immature CD24hi, middle panels showmature
CD24loCD44hiNK1.1, and right panels show terminally differentiated CD24loCD44hiNK1.1+ cells in the thymus (black) and spleen (gray). The findings
are summarized in the NKT cell developmental chart below the FACS panels.
(C) Immunohistochemical staining of thymi for Slamf1 (left) and Slamf6 (right) expression (in red) as well as cortical epithelial cells (antibody 6C3 in
green).
(D) Flow cytometry analysis of thymic CD11b+ macrophages and CD11c+ dendritic cells (red) compared with DP thymocytes (green). The blue profile
corresponds to a staining with biotin-conjugated antibody after incubation with excess unconjugated (cold) antibody (negative control). One of three
experiments with similar results is shown.from other thymic cell types, including epithelial cells,
dendritic cells, and macrophages, with the exception of
a subset of CD11c+ cells expressing Slamf6 (Figures
2C–2D).
NKT Cells in Slamf1- or Slamf6-Deficient Mice
By using flow cytometry, we compared the thymus,
spleen, and liver lymphocytes of Slamf6+/ and Slamf6/
littermate pairs as well as Slamf1+/ and Slamf1/ litter-
mate pairs and found little difference in NKT cell numbers
in most cases. These results are consistent with previous
reports of Slamf6- (Howie et al., 2005), Slamf1- (Wang
et al., 2004) or Slamf3- (Graham et al., 2006) deficient
mice. The compilation of data did suggest a modest re-
duction (50%) in the case of Slamf6/ mice (Figure 3).754 Immunity 27, 751–762, November 2007 ª2007 Elsevier IncTo reveal latent, intrinsic NKT cell defects associated
with these mutations, we generated radiation chimeras
in which lethally irradiated Ja18-deficient hosts were
competitively reconstituted with a 1:1 mixture of wild-
type and Slamf1- or Slamf6-deficient bone marrow cells
expressing different marker alleles of CD45 for convenient
FACS identification. In all these chimeras, the knockout
(KO):WT ratio of thymocytes and splenocytes ranged
between 0.3 and 0.7, demonstrating the similar capacity
of WT and KO bone marrow cells for general lymphocyte
reconstitution. Significant NKT cell decreases of 50%–
75% on average were observed for both the Slamf1-
and the Slamf6-deficient populations compared with the
wild-type (Figure 4A). Because the Slamf1-deficient and
the Slamf6-deficient bone marrows used in these.
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from embryonic stem cells of 129 origin and were subse-
quently backcrossed to B6, the possibility existed that
these relatively modest differences resulted from some
heterogeneity between the SLAM locus of 129 and B6.
We thus generated control mixed chimeras withmutations
of Slamf4 and Slamf2, which encode 2B4 (CD244) and its
ligand CD48, respectively. Both proteins are encoded in
the same SLAM locus, but they should not affect NKT
cell development because, whereas Slamf2 is highly
expressed by all immature and mature thymocytes,
Slamf4 is not expressed in the thymus or during NKT cell
development (data not shown). The Slamf4 mutants
were derived from embryonic stem cells of B6 origin,
and the Slamf2 mutants were derived from embryonic
stem cells of 129 origin and backcrossed onto the B6
genetic background. In such control (Slamf4/ +Slamf6/)
or (Slamf2/ + Slamf6/) mixed chimeras, the develop-
ment of NKT cells lacking Slamf6 was as defective relative
to NKT cells lacking Slamf4 or Slamf2 as it was relative
to wild-type NKT cells in the (WT + Slamf6/) mixed
chimeras (Figure 4A). An additional set of control (WT +
Slamf2/) chimeras directly demonstrated that the
SLAM locus from 129 did not contribute to the NKT cell
defects observed in Slamf1/ or Slamf6/ mice
(Figure 4A).
A more detailed analysis of the NKT cell developmental
stages in these mixed chimeras revealed a clear defect at
the transition between the CD24hi and CD24lo stages in
the Slamf1- or Slamf6-deficient cells compared with the
Figure 3. Individual Contributions of Slamf1 and Slamf6 to
NKT Cell Development
Scatter plots showing absolute numbers (log2 scale) of CD1d-
aGalCer-positive cells in individual thymi, spleens, and livers of 3–5-
week-old Slamf1+/ and Slamf1/ littermates and Slamf6+/ and
Slamf6/ littermates. Because of variations in liver lymphocyte recov-
ery between experiments, liver NKT cell numbers are enumerated per
105 lymphocytes. Liver NKT cells were not examined inSlamf1/mice
(‘‘ND’’ indicates not determined). ‘‘*’’ indicates statistical significance
(p < 0.05) with an unpaired t test.Imwild-type (Figure 4B). This transition corresponds to the
phase of expansion of the NKT cell lineage after positive
selection has occurred. Thus, both Slamf1 and Slamf6
contribute to the development of NKT cells after positive
selection.
Slamf1 and Slamf6 Double Deficiency
Owing to their overlapping expression pattern and their
shared usage of SAP and Fyn for intracellular signaling,
Slamf1, Slamf6 and some of the other SLAM family recep-
tors might be partly redundant in the thymus, as well as in
peripheral immune responses. Because they are encoded
in the same locus, however, double- or triple-mutant mice
could not be generated by the breeding of single mutants.
Instead, we reconstituted lethally irradiated Ja18-defi-
cient hosts with a 1:1 mixture of CD45-allele-marked
CD1d-deficient bone marrow that lacked Slamf6
(Slamf6/CD1d/) and CD1d-sufficient bone marrow
that lacked Slamf1. In these chimeras, NKT cell precur-
sors originating from the CD1d/ compartment lacked
Slamf6 and were forced to engage their TCR on CD1d-
expressing thymocytes that lacked Slamf1, creating
a special ‘‘double-mutant’’ situation during these cell
encounters because neither Slamf1 nor Slamf6 could
engage in homophilic self-interactions (Figure 5A, top).
These Slamf6/CD1d/ precursors, however, were
able to receive Slamf1 signals from bystander thymocytes
in trans. In contrast, the Slamf1/ cells had to interact
with other Slamf1/ cells for their TCR to see CD1d, cre-
ating a single-mutant situation (Figure 5A, bottom). In the
thymus and peripheral tissues of these chimeras, the dou-
ble-mutant cells generated on average six to ten times
less NKT cells than did the single-mutant cells (Figures
5B and 5C, first column). Control chimeras expressing
a 1:1 mixture of wild-type and CD1d/ bone marrow
demonstrated that the absence of CD1d on half of the
thymocytes did not interfere with NKT cell development
(Figures 5B and 5C, fourth column). Notably, in these
mixed chimeras, as in those shown in Figure 4A compar-
ing Slamf2/ and Slamf6/, the NKT cell precursors
shared the same SLAM locus of 129 origin and differed
only with respect to the Slamf1 and Slamf6 mutations.
Taking into account the fact that the Slamf1/ cells,
against which the Slamf6/CD1d/ cells were compet-
ing, were themselves impaired by 50% when compared
with wild-type (Figure 4), the findings suggest that the
combined interruption of homophilic Slamf1-Slamf1 and
Slamf6-Slamf6 interactions between the CD1d-present-
ing thymocyte and the NKT precursor results in a 92%–
95% reduction in NKT cell development that cannot be
rescued by ‘‘bystander’’ interactions with other thymo-
cytes expressing these receptors. As expected from
previous studies of SAP- and Fyn-deficient mice, the de-
velopment of conventional CD4+ and CD8+ T cells was
not altered in the mixed chimeras (data not shown).
A second set of mixed chimeras was constructed with
a 1:1 mixture of Slamf1/ and Slamf6/ bone marrow
cells. In these chimeras, a NKT cell precursor lacking
Slamf1, for example, will be deprived of Slamf1 interactionsmunity 27, 751–762, November 2007 ª2007 Elsevier Inc. 755
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(A) 1:1 mixtures of WT + Slamf1/, WT + Slamf6/, WT + Slamf2/, Slamf4/ + Slamf6/, and Slamf2/ + Slamf6/ bone marrow were injected
into lethally irradiated Ja18/ hosts, and chimeras were analyzed at 6–8 weeks. Absolute NKT cell numbers were calculated for each CD45 allele-
marked compartment and were then divided by the number of lymphocytes in the corresponding CD45 allele-marked fraction and multiplied by the
total number of lymphocytes to adjust for differences between the ratio of reconstitution by the two bonemarrowswhich ranged between 0.3 and 0.7.
‘‘*,’’ ‘‘**,’’ and ‘‘***’’ indicate statistical significance (p < 0.05, p < 0.01, and p < 0.001, respectively) with a t test for paired comparisons (2 experiments
are pooled as they showed similar results [ANOVA]).
(B) FACS analysis of MACS-enriched CD1d-aGalCer tetramer+ CD24hi and CD24lo cells originating from the WT and mutant (CD45 allele-marked)
bone marrows. The chimeric distribution of the tetramer-negative thymocytes is also shown (bottom dot plots).permanently but will also miss Slamf6 interactions in 50%
of its cellular interactions because the other half of the thy-
mocytes lacked Slamf6. Interestingly, these competitive
chimeras suggested that the impact of Slamf6 might be
more important than that of Slamf1 because on average
the absence of Slamf6 resulted in 50%–75% less NKT756 Immunity 27, 751–762, November 2007 ª2007 Elsevier Inc.cells than did the absence of Slamf1 (Figures 5B and 5C,
second column). This might be due to the persisting ex-
pression of Slamf6 after the DP stage (Figure 2B) because
it is known that NKT cell precursors continue to engage
their TCR for an extended period of time until terminal mat-
uration into NK1.1+ cells (McNab et al., 2005). In addition,
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meras in the first and second columns of Figures 5B and
5C showed that the lack of CD1d in the Slamf6/ com-
partment further increased the magnitude of the NKT
cell defects in comparison with the Slamf1/ compart-
ment in different tissues by 3-fold on average (Figure 6)
(p < 0.001, analysis of variance [ANOVA]), demonstrating
that functionally relevant self-interactions between
SLAM family members occurred at the same time as
TCR engagement and with the same CD1d-expressing
thymocyte. This conclusion was further supported by re-
verse chimeras made of a 1:1 mixture of Slamf6/ and
Slamf1/CD1d/ bone marrows (Figures 5B and 5C,
third column) in which the functionally double-mutant
Slamf1/CD1d/ population now generated less NKT
cells than did the single-mutant Slamf6/ population.
The statistical comparison of the two sets of mixed chi-
meras in the second and third columns of Figures 5B
and 5C showed that the ablation of CD1d in the
Slamf1/ cell population, functionally changing these
cells into double mutants, increased the magnitude of its
NKT cell defect by 6-fold on average in different tissues
(Figure 6) (p < 0.001, ANOVA). The ratios of NKT cells
developing in the different compartments of individual
mixed chimeras are summarized in Figure 6. Altogether,
these results reveal the partial redundancy of Slamf1
and Slamf6 and demonstrate that their homophilic en-
gagement during cognate TCR-CD1d interaction is critical
to NKT cell development.
DISCUSSION
TCR and CD4-CD8 coreceptor signaling events are
central to the selection and lineage differentiation of thy-
mocytes. However, the characterization of new lineages
recognizing ligands presented by cells as divergent from
thymic epithelial cells as cortical thymocytes has sug-
gested that unidentified, cell-type specific signals might
also decisively impact the selection and differentiation
events. The present study identified two members of the
SLAM family of receptors, Slamf1 and Slamf6, that are
highly expressed by cortical thymocytes and control the
transition between positive selection and the subsequent
expansion and differentiation of the NKT cell lineage. NKT
cell precursors lacking either Slamf1 or Slamf6 exhibited
only modest defects. However, in mixed bone-marrow
chimeras designed to abrogate both Slamf1 and Slamf6
signaling during CD1d ligand recognition in the thymus,
a stronger developmental arrest was observed, demon-
strating that Slamf1 and Slamf6 exerted essential and
intrinsic but partly redundant effects through homophilic
self-association across the cell-cell synapse. The demon-
stration that Slamf1 and Slamf6 could exert partially
redundant effects is consistent with their shared recruit-
ment of SAP and Fyn and might suggest an explanation
for the past failure of investigators to ascribe the multiple
phenotypes associated with the SAP or Fyn deficiencies
to individual members of the SLAM family of receptors
(Veillette, 2006). Deficiencies of Slamf1, Slamf6, or theirImintracellular signaling partners Fyn and SAP affected
NKT cell development with increasing severity. It is possi-
ble therefore that the residual NKT cells developing in
mixed Slamf1 + Slamf6 ‘‘pseudo-double KO’’ chimeras
have signaled through other, less prominent SLAM family
receptors, such as Slamf3 (Ly9, CD229), Slamf5 (CD84), or
Slamf7 (CRACC, CD319), for example. Alternatively, by-
stander engagement of Slamf1 and Slamf6 by third-party
cortical thymocytes (not directly involved in TCR-CD1d
ligand interactions) might have provided the required sig-
nals, albeit inefficiently. This issue will be resolved when
double and triple mutants of the SLAM family of receptors
become available.
All mutations impacted the same stage of NKT cell de-
velopment, further supporting a linear model of signaling
through SLAM family receptors and intracellular SAP
and Fyn. Thus, whereas CD24hiCD69hiTetr+ cells, repre-
senting the stage just after positive selection, were clearly
identified, the subsequent intrathymic expansion and
differentiation of NKT cells was invariably defective. These
results stand in contrast with a previous conclusion that
Fyn acted upstream of TCR expression on the basis of
the apparent restoration of NKT cells in Fyn-deficient
mice upon the expression of a Va14-Ja18 transgene
(Gadue et al., 2004). The reasons for this discrepancy
are unclear, but our own experiments clearly demon-
strated that NKT cell development was severely quantita-
tively impaired in Va14-Ja18 transgenic mice lacking
either Fyn or SAP. One possibility is that the overexpres-
sion of the TCR transgene combined with the leakiness
of the Fyn mutation might have resulted in the apparent
‘‘rescue’’ of NKT cells in the discordant report. Another,
nonexclusive possibility is that the rescued cells in these
transgenic mice corresponded to a subset of tetramer-
positive, CD1d-independent, non-NKT lineage cells,
which used a prematurely expressed Va11 promoter to
drive Va14-Ja18 expression (Bendelac et al., 1996; Wei
et al., 2006). These cells are not present in our new trans-
genic lines that use a CD4 promoter. In any case, the pres-
ent combined results render the previous conclusion that
Fyn was involved prior to TCR engagement speculative
and, instead, support a unified model in which the bifurca-
tion of the NKT cell lineage is driven by the peculiar signals
emanating through SLAM family receptors, SAP and Fyn
at the intercellular synapse formed during the thymic se-
lection events. These findings help focus the search for
the mechanisms of developmental arrest during the
events associated with CD1d ligand recognition rather
than during some defective TCR arrangement or lineage
precommitment. The arrested cells did not exhibit signs
of increased apoptosis and could not be rescued by
a Bcl-xL transgene driven by a proximal Lck promoter
(data not shown), suggesting that, rather than a mere
lack of a survival signal, a defect in positive selection,
a block in proliferation, or an increased negative selection
might also underlie the developmental defect.
Signaling through SAP and Fyn is reported to activate
SHIP1, Dok1 and Dok2, and RasGap and to inhibit Ras
signaling (Veillette, 2006). Fyn also activates the NF-kBmunity 27, 751–762, November 2007 ª2007 Elsevier Inc. 757
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Slamf Receptors Control NKT Cell DevelopmentFigure 5. NKT Cell Developmental Block in Pseudo-Double KO Chimeras
(A) Cell interaction schemes illustrating the functional double deficiency created in the CD1d/ compartment of mixed chimeras of the Slamf1/ +
Slamf6/CD1d/ (top) versus the single deficiency in theCD1d+/+ compartment (bottom). TheSlamf6/CD1d/NKT cell precursorsmust interact
with Slamf1/ thymocytes, the sole source of CD1d ligands, functionally removing both Slamf1 and Slamf6 signals during TCR engagement (top),
whereas the Slamf1/ NKT cell precursors must interact with Slamf1/ thymocytes, creating a single KO situation (bottom).
(B) Mixed radiation bone-marrow chimeras as indicated. FACS dot plots are gated on CD1d-aGC+ NKT lineage cells and show the expression of the
CD45.1 allelic marker in tetramer-positive and -negative cells in different tissues, as indicated.758 Immunity 27, 751–762, November 2007 ª2007 Elsevier Inc.
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Slamf Receptors Control NKT Cell Developmentpathway (Cannons et al., 2004), whose importance for
NKT cell development, particularly for survival, is well es-
tablished (Schmidt-Supprian et al., 2004; Sivakumar et al.,
2003; Stanic et al., 2004). The coordinated expression of
CD1d and SLAM-family members in mouse and human
thymocytes, segregated from MHC class I and class II in
thymic stromal cells, favors the spatial and temporal co-
signaling of SLAM family members along with the TCR
during NKT cell development. Notably, because Slamf1
and Slamf6 signaling appears to be required concomi-
tantly with TCR engagement, it would not be available to
mainstream thymocytes because they interact with MHC
ligands on stromal cells (which do not express these
SLAM family members). Thus, our findings suggest that
the peculiar thymic expression patterns of MHC, CD1d,
and SLAM family glycoproteins in mouse and human
dictate alternative lineage fates. The topography of ligand
expression defines therefore a specialized niche that
provides the necessary signals for divergent lineage differ-
entiation.
Interestingly, recent reports have suggested that the
inactivation of the Tec kinases, which signal downstream
of the TCR, induced a shift from the conventional T cell to
a memory or effector NK1.1+ ‘‘innate-like’’ T cell lineage
Figure 6. Relative Contribution of Slamf1 and Slamf6 in
Pseudo-Double KO Chimeras
Summary scatter plot showing the calculated ratios of NKT cells
found in the two bone-marrow-derived compartments of individual
chimeras in Figures 5B and 5C. A two-way ANOVA test showed
statistically significant differences between the ratios found in different
chimera sets.Imthrough the induction of eomesodermin and the interleu-
kin-2 (IL-2) receptor b chain (Atherly et al., 2006; Brous-
sard et al., 2006), a striking parallel to the induction of
T-bet, a homolog of eomosodermin, and the IL-2 receptor
b chain required for the NKT cell lineage (Intlekofer et al.,
2005; Matsuda et al., 2006; Townsend et al., 2004). The
development of these MHC-restricted innate-like T cells
required MHC class I expression on bone-marrow-
derived rather than epithelial cells. Likewise, normal or
transgenic expression by thymocytes of MHC class Ib or
MHC class II, respectively, resulted in the development
of memory or effector type T cells (Choi et al., 2005; Li
et al., 2005; Urdahl et al., 2002). These intriguing findings
might indicate that SLAM family receptor signaling is
generally involved in the formation of memory or effector
innate-like lineages by bone-marrow-derived thymocytes
and suggest novel mechanisms of lymphocyte lineage
instruction based not only on TCR and coreceptor signals
but also on accessory signals specifically provided by
different antigen-presenting cell types. Indeed, recent
findings indicate that SAP is essential for the development
of these innate-like lineages, as well (Horai et al., 2007;
Li et al., 2007 [both in this issue of Immunity]).
Notably, polymorphism at the SLAM locus, in particular
the differential expression of Slamf6 splice variants with
differential signaling properties, is associated with autoim-
munity and lupus (Kumar et al., 2006; Wandstrat et al.,
2004). The absence of Slamf1 expression on thymic DP
cells was recently reported in nonobese diabetic (NOD)
mice, a phenotype correlating with homozygosity for the
SLAMNOD locus in genetic analysis (Jordan et al., 2007).
The link between Slamf1 and variations in NKT cell num-
bers remains correlative, but it is consistentwith aprevious
mapping of NKT cell deficiency in this autoimmune strain
identifying two independent loci, Nkt1 and Nkt2 (Jordan
et al., 2007; Rocha-Campos et al., 2006), because the
SLAM locus is a candidate for Nkt1. Although Nkt1 con-
genic NODmice did not show the amelioration of diabetes
(Rocha-Campos et al., 2006), the NKT cell increase in
these mice was modest, and the role of NKT cells in
type I diabetes remains intriguing (Delovitch and Singh,
1997).
Although previous research emphasized the role of
SLAM family receptors in multiple forms of innate and
adaptive immune responses, our findings reveal a new
essential role of the SLAM family of receptors in lympho-
cyte development and further suggest a more general
mechanism of T cell lineage differentiation through the
topologically segregated expression of TCR ligands and
costimulatory receptors. The results also strengthen the
emerging concept that polymorphism of the SLAM locus
might underlie important genetic variations in the develop-
ment or function of entire populations of immune cells to
fine-tune the balance between the effector and regulatory
pathways that control infection and autoimmunity.(C) Summary scatter plots show NKT cell numbers in different tissues and in CD45 allele-marked compartments of individual mixed chimeras. ‘‘*,’’
‘‘**,’’ and ‘‘***’’ indicate statistical significance (p < 0.05, p < 0.01, and p < 0.001, respectively) with a t test for paired comparisons of the two hemo-
poietic compartments in individual mixed chimeras. Results are pooled from two to three sets of chimeras showing similar results (ANOVA).munity 27, 751–762, November 2007 ª2007 Elsevier Inc. 759
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Mice
Slamf1/ (Wang et al., 2004) mice were used after eight backcrosses
to C57BL/6, Slamf6/ (Howie et al., 2005) (lacking exons 2–3 encod-
ing the entire extracellular domain) after six backcrosses, Slamf2
(Cd48)/ after 12 backcrosses, Sh2d1a (SAP)/ (Wu et al., 2001)
and Fyn/ (Stein et al., 1992) after ten backcrosses, and Ja18/
(Cui et al., 1997) and CD1d/ (Carnaud et al., 1999) after > 12 back-
crosses. Slamf4 (2B4)/were on a pure C57BL/6 background (Vaidya
et al., 2005). C57BL/6 (CD45.2) and B6.SJL-Ptprca Pep3b/BoyJ
(CD45.1) were from Jackson Labs. We verified that Slamf1/,
Slamf6/, and Slamf2/ mice shared the same SLAM locus of 129
origin by using strain-specific antibodies against Slamf3 (Ly9) and
Slamf4 (CD244, 2B4) and by genotyping for a SNP rs315321197 lo-
cated at the other end of the locus (data not shown). For the generation
of the Va14-Ja18 transgenic mice, the prerearranged Va14-Ja18 TCR
a chain complementary DNA (cDNA) of the DN32.D3 hybridoma
(Bendelac et al., 1996) was inserted into the SalI site of a plasmid
containing the minimal CD4 promoter and enhancer and the intronic
silencer (Sawada et al., 1994). The linearized (via NotI) construct was
injected into fertilized C57BL/6 oocytes, and the injected oocytes
were implanted into pseudopregnant CD-1 (VAF+) outbred female
mice. Transgenic mice were screened with polymerase chain reaction
(PCR) (forward primer: 50-TGTAGGCTCAGATTCCCAACC-30; reverse
primer: 50-GAGGATGGAGCTTGGGAGTCAGG-30) and were bred
onto various gene-deficient backgrounds. All mouse work was done
in accordance with the guidelines of the Institutional Animal Care
and Use Committee at the University of Chicago.
Antibodies and Flow Cytometry
Anti-Slamf6 (clone 13G3)was generated from the spleen of aSlamf6/
mouse immunized with wild-type thymocytes (S.R., unpublished data)
and anti-Slamf5 mAb (a generous gift from Pablo Engel) was reported
(Romero et al., 2005). CD1d-aGalCer tetramers were prepared as pre-
viously described (Benlagha et al., 2000). Fluorochrome labeledmono-
clonal antibodies (clone indicated in parentheses) against Slamf1
(9D1), Slamf3/CD229.1/Ly9.1 (30C7), Ep-CAM (G8.8), Ly51 (6C3),
NK1.1 (PK136), CD44 (IM7), CD24 (M1/69), B220 (RA3-6B2), CD8a
(536.7), CD4 (RM4-5), CD45 (30-F11), CD11c (HL3), CD11b (M1/
70), CD1d (1B1), CD45.1 (A20), rat k light chain (MRK1), and were
purchased from eBioscience or BDBiosciences. The FITC-conjugated
anti-Syrian and Armenian hamster IgG cocktail (G70-204, G94-56) was
purchased fromBDBiosciences. For NKT cell enrichment, thymocytes
were stained with APC-conjugated CD1d-aGalCer tetramers, bound
to anti-APC paramagnetic beads and positively selected with an auto-
MACS (Miltenyi biotech) as described (Benlagha et al., 2005). All steps
were performed at ice-cold temperature. Samples were analyzed on
BD Canto or LSRII flow cytometers. Dead cells were excluded with
DAPI staining and doublets by gating on FSC and SSC area, height
and width.
Generation of Mixed Bone-Marrow Chimeras
Four to eight-week old Ja18/ mice were subjected to 900 Rads
irradiation using a gamma cell 40 irradiator with a cesium source.
Four to eight hours later, irradiated mice were injected intravenously
with 5x106-107 bone marrow cells isolated from femurs of donor
mice, and depleted of T cells by magnetic cell sorting (autoMACS,
Miltenyi biotech) using CD3-PE antibody (eBiosciences) and anti-PE
beads. Mice were analyzed six to eight weeks after reconstitution.
Quantitative Real-Time PCR of Canonical Va14-Ja18
CD4+CD8+CD24hi thymocytes were sorted from C57Bl/6, CD1d/,
Sh2d1a/, Fyn/, and Ja18/ mice on FACSAria (BD Biosciences)
and MoFlo (Dako Cytomation) cell sorters. Total RNA of 53 105 sorted
thymocytes was extracted into 10 ml and treated with DNase1 with the
RNAqueous Micro Kit (Ambion). Eight microliters of each DNase1-
treated RNA sample was primed with oligo-dT and reverse transcribed760 Immunity 27, 751–762, November 2007 ª2007 Elsevier Inc.into a 20 ml volume with the SuperScript III Platinum Two-Step
qRT-PCR kit (Invitrogen). Va14 and Ca-specific primers, as well as
the Ca-specific Taqman probe, were previously described. A probe
specific for the sequence spanning the NKT cell clonotypic Va14-
Ja18 junction (50-FAM-CTGTGTGGTGGGCGATA-MGBNFQ-30) was
purchased from Applied Biosystems. PCR reactions were run in an
ABI Prism 7700 Sequence Detector (Applied Biosystems). Each dupli-
cate reaction contained 5 ml cDNA, 0.2 mM each primer and Taqman
probe, and Platinum Quantitative PCR Supermix-UDGwith ROX refer-
ence dye (Invitrogen) to a final volume of 50 ml. Initial 2 min holds at
50C and 95C were followed by 50 cycles consisting of 15 s at
95C and 45 s at 60C. Amplification was analyzed with ABI Prism
Sequence Detection Software Version 1.9.1 (Applied Biosystems)
and the Standard Curve Method described in the ABI Prism 7700
Sequence Detection System User Bulletin #2. Ten-fold serial dilutions
of a plasmid containing a rearranged Va14 TCRa cDNA were used for
Va14 and Ca standard curve generation.
Immunohistochemistry
Thymi from 4-week-old C57Bl/6 mice were rinsed with phosphate-
buffered saline (PBS) and frozen in optimal cutting temperature
(OCT) freezing medium (Tissue-Tek, Sakura Finetek) by flotation on
2-methylbutane (Sigma-Aldrich) over dry ice. Frozen thymi were stored
at 80C. Thymic sections were cut at 6 mm on a LEICA microtome,
fixed with aceton for 5 min, and stained with purified anti-Slamf1
(9D1) and a Cy3 TSA amplification system (Perkin Elmer) or biotiny-
lated anti-Slamf6 (13G3) and then streptavidin-rhodamin- (Molecular
Probes) and fluorecein isothiocyanate (FITC)-conjugated anti-Ly51
(6C3) (a marker for cortical epithelium). Images were captured on a
Leica SP2 A OBS Laser Scanning Confocal and a Zeiss Axiovert 200
immunofluorescence microscope and processed with LCS Leica
Confocal Software, Openlab software, and Adobe Photoshop.
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